Skip to main content



Local Cdiff information for Washington

Washington

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Washington.



Local Cdiff information for Washington

Washington

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Washington.

Providers

Dr. David Suskind, MD

Director, Quality Improvement; Co-chair, Nutrition Subcommittee
Seattle Children’s – Gastroenterology and Hepatology
4800 Sand Point Way NE
Seattle, 98105
(206) 987-2521
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 1191
Hospital Onset: 1191
Community Onset: Not reported
Related Deaths: 150+ (2008)

Available Reports

Annual Progress based on SIR: 0.75
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: Yes
LTC Facility Data Publicly Reported: No
Law/Regulation: WAC 246-440-100
STATUTE >

State Contact

Marisa A. D’Angeli, MD, MPH
Medical Epidemiologist
Washington State Department of Health
Division of Disease Control and Health Statistics, Healthcare Associated Infections Program
PO Box 47811
Olympia, 98504
(206) 418-5595
EMAIL MARISA A. D’ANGELI, MD, MPH >

CLINICAL TRIALS

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.